Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 1/20 | 0.57 |
| ▸ | GPR119 | Q8TDV5 | 9/20 | 0.45 |
| ▸ | ALOX5AP | P20292 | 3/20 | 0.41 |
| ▸ | FEN1 | P39748 | 3/20 | 0.41 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.40 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.40 |
| ▸ | HPGDS | O60760 | 2/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21264882 | 1.00 | MET (0.57) | METGPR119ALOX5APFEN1SLC2A1 | |
| SCHEMBL21322099 | 0.91 | MET (0.57) | METGPR119ALOX5APFEN1SLC2A1 | |
| SCHEMBL21264883 | 0.90 | MET (0.52) | METGPR119ALOX5APFEN1SLC2A1 | |
| SCHEMBL23714116 | 0.90 | MET (0.54) | METGPR119ALOX5APFEN1SLC2A1 | |
| SCHEMBL21264730 | 0.87 | MET (0.52) | METGPR119ALOX5APFEN1SLC2A1 | |
| SCHEMBL21264609 | 0.87 | MET (0.55) | METGPR119ALOX5APFEN1SLC2A1 | |
| SCHEMBL21322097 | 0.87 | MET (0.52) | METGPR119ALOX5APFEN1SLC2A1 | |
| SCHEMBL21322263 | 0.87 | MET (0.55) | METGPR119ALOX5APFEN1SLC2A1 | |
| SCHEMBL21264884 | 0.87 | MET (0.55) | METGPR119ALOX5APFEN1SLC2A1 | |
| SCHEMBL21264736 | 0.85 | MET (0.80) | METGPR119ALOX5APFEN1SLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3533787-A1 | PYRIDONE COMPOUND AS C-MET INHIBITOR | Fujian Cosunter Pharmaceutical Co., Ltd. (CN) | 2019-09-04 | — | — | EP | disclosed |